The DOI matches its Crossref record.
Early Detection of Sporadic Pancreatic Cancer: Summative Review
Open accessAbstract
Pancreatic cancer (PC) is estimated to become the second leading cause of cancer death in the United States by 2020. Early detection is the key to improving survival in PC. Addressing this urgent need, the Kenner Family Research Fund conducted the inaugural Early Detection of Sporadic Pancreatic Cancer Summit Conference in 2014 in conjunction with the 45th Anniversary Meeting of the American Pancreatic Association and Japan Pancreas Society. This seminal convening of international representatives from science, practice, and clinical research was designed to facilitate challenging interdisciplinary conversations to generate innovative ideas leading to the creation of a defined collaborative strategic pathway for the future of the field. An in-depth summary of current efforts in the field, analysis of gaps in specific areas of expertise, and challenges that exist in early detection is presented within distinct areas of inquiry: Case for Early Detection: Definitions, Detection, Survival, and Challenges; Biomarkers for Early Detection; Imaging; and Collaborative Studies. In addition, an overview of efforts in familial PC is presented in an addendum to this article. It is clear from the summit deliberations that only strategically designed collaboration among investigators, institutions, and funders will lead to significant progress in early detection of sporadic PC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“If the stage distribution could be reversed, to 50% localized and 10% metastatic, survival would be more than doubled without any additional improvements in therapy.3”
From Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review (2021) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and the currently used blood-based biomarker, CA 19-9, accurately predicts only 65% of those with early disease when surgical treatment is a viable option.3,167”
From Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review (2021) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, screening in the asymptomatic population is not recommended due to the economic burden and the relatively low incidence of PC in the general population 21,22.”
From Artificial intelligence in pancreatic cancer (2022) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Early symptoms of the disease are mostly nonspecific.”
From Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review (2021) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, the size of the lesion at the time of surgery is a predictor of long-term survival.3,166,167”
From Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review (2021) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“Several studies have shown that early detection of PDAC improves outcome.”
From Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review (2021) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“This result is based on the findings that surgery is the only therapy to date associated with a durable long-term outcome.”
From Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review (2021) · cites this paper as [3]
In the citing paper
“a multitude of circulating tumor-derived analytes (proteins, autoantibodies, metabolites, DNA, non-coding RNAs and extracellular vesicles, among others) have been assessed in the context of PDAC early detection39–41.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Still being checked.
Research works printed but not linked: 1
- References are available online at: http://links.lww.com/MPA/A374.
Cited by
Sorted by citations
Items 201–295 of 295
Pankreaskarzinom – Pathologie, Ätiologie und diagnostisches Vorgehen
Belyaev, O., & Uhl, W. H. (2019) · Allgemein- und Viszeralchirurgie up2date · doi:10.1055/a-0953-2938 · Cited by 4
Belyaev, O., Bösch, F., Brunner, M., Müller-Debus, C. F., Radulova‐Mauersberger, O., Wellner, U. F., Grützmann, R., Keck, T., Werner, J., Witzigmann, H., et al. (2020) · Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie · doi:10.1055/a-1161-9501 · Cited by 4
Choi, M. H., Tjora, E., Forthun, R. B., Engjom, T., Ræder, H., Hovland, R., & Molven, A. (2021) · Pancreatology · doi:10.1016/j.pan.2021.09.010 · Cited by 4
Bantis, L. E., & Tsimikas, J. (2022) · Statistics in Medicine · doi:10.1002/sim.9432 · Cited by 4
Biomarkers for the Early Detection of Pancreatic Ductal Adenocarcinoma
Borrebaeck, C. A. K., Mellby, L. D., & King, T. C. (2022) · Exon Publications eBooks · doi:10.36255/exon-publications-gastrointestinal-cancers-biomarkers-pancreatic-cancer · Cited by 4
A 3-Decade Analysis of Pancreatic Adenocarcinoma After Solid Organ Transplant
Corral, J. E., Croome, K. P., Keaveny, A. P., Brahmbhatt, B. S., Kröner, P. T., Wijarnpreecha, K., GOSWAMI, R. M., Raimondo, M., Wallace, M. B., Bi, Y., et al. (2020) · Pancreas · doi:10.1097/mpa.0000000000001722 · Cited by 4
Development of Pancreatic Cancer: Targets for Early Detection and Treatment
Lerch, M. M., Mayerle, J. V., Mahajan, U. M., Sendler, M., Weiß, F. U., Aghdassi, A. A., Moskwa, P., & Simon, P. (2016) · Digestive Diseases · doi:10.1159/000445233 · Cited by 4
Self-citationWhy is pancreatic adenocarcinoma not screened for earlier?
Maroni, L., Ravaioli, M., & Pinna, A. D. (2016) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2016.1224972 · Cited by 4
Pickett, M., Kamra, M., Castilla‐Casadiego, D. A., Noori, S., Matsui, W. H., Rosales, A. M., Zoldan, J., & Parekh, S. H. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.11.031 · Cited by 3
Diabetes Status and Pancreatic Cancer Survival in the Nationwide Veterans Affairs Healthcare System
Khalaf, N. I., Kramer, J. R., Liu, Y., Abrams, D., Singh, H., El‐Serag, H. B., & Kanwal, F. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-08035-8 · Cited by 3
Recent advances in molecular diagnostics and therapeutic targets for pancreatic cancer
Clay, R., & Siddiqi, S. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819457-7.00016-5 · Cited by 3
Development of Novel Diagnostic Pancreatic Tumor Biomarkers
Oldfield, L. S., Rao, R. G., Barrera, L. N., & Costello, E. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_86 · Cited by 3
Imamura, H., Hirose, H., Endo, S., Hashimoto, Y., Takeda, M., Kidogami, S., Mokutani, Y., Kishimoto, T., Yoshioka, S., Tamura, S., et al. (2020) · Surgical Case Reports · doi:10.1186/s40792-020-01035-0 · Cited by 3
Bueno, F. S., García-Pérez, R., Valderas, M. A. C., Moral, J. D. L. P., Esteban, L. F., Ruiz, E. O., Quiñonero, M. F., & Paricio, P. P. (2016) · Cirugía Española (English Edition) · doi:10.1016/j.cireng.2016.11.006 · Cited by 3
Eyff, T. F., Bosi, H. R., Mariana Sandrin, T. O. N. I., Zilio, M. B., Corso, C. O., Bersch, V. P., & Osvaldt, A. B. (2018) · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · doi:10.1590/0102-672020180001e1366 · Cited by 3
Tanaka, R., Kageyama, K., Kimura, K., Eguchi, S., Tauchi, J., Shinkawa, H., Ohira, G., Yamazoe, S., Yamamoto, A., Tanaka, S., et al. (2020) · Anticancer Research · doi:10.21873/anticanres.14234 · Cited by 3
Shin, W., Kang, K., & Jang, H. (2018) · Preprints.org · doi:10.20944/preprints201807.0226.v1 · Cited by 3
Cholesterol deprivation induces TGFβ signaling to promote basal differentiation in pancreatic cancerPreprint
Gabitova-Cornell, L., Peri, S., Restifo, D., Klochkova, A., Hartman, T. R., O’Reilly, A. M., Francescone, R. A., III, Franco‐Barraza, J., Shah, N., Nicolas, É., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/633719 · Cited by 3
Fei, S., Ohuchida, K., Kibe, S., Yan, Z., Iwamoto, C., Shinkawa, T., Zhang, B., Kawata, J., Abe, T., Ideno, N., et al. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04554-5 · Cited by 2
Lee, M., Yu, M. H., Chae, W., Lee, Y., Lee, B. I., Kang, E. S., Cha, B., Jang, S., & Chung, M. J. (2026) · Gut · doi:10.1136/gutjnl-2025-335863 · Cited by 2
Nakano, R., Nishiumi, S., Kobayashi, T., Ikegawa, T., Kodama, Y., & Yoshida, M. (2020) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0587 · Cited by 2
Bueno, F. S., García-Pérez, R., Valderas, M. A. C., Moral, J. D. L. P., Esteban, L. F., Ruiz, E. O., Quiñonero, M. F., & Paricio, P. P. (2016) · Cirugía Española · doi:10.1016/j.ciresp.2016.07.007 · Cited by 2
Diagnostic Value and Interreader Agreement of the Pancreaticolienal Gap in Pancreatic Cancer on MDCT
Schawkat, K., Kühn, W., Inderbitzin, D., Gloor, B., Heverhagen, J. T., Runge, V. M., & Christe, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166003 · Cited by 2
The Role of Epigenetics in Pancreatic Ductal Adenocarcinoma
Roalsø, M. T. T., Hald, Ø. H., Ansari, D., Andersson, R. E., & Søreide, K. (2021) · Springer eBooks · doi:10.1007/978-3-030-53786-9_22 · Cited by 2
Lyu, S., Wang, H.-X., Liu, Z., Wang, J., Huang, J., He, Q., & Lang, R. (2022) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v14.i11.1204 · Cited by 2
The Countdown to a Paradigm Shift in Diagnosing Pancreatic Ductal Adenocarcinoma
Coté, G. A. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.03.003 · Cited by 2
New‐onset Diabetes as a Harbinger of Pancreatic Cancer: is Early Diagnosis Possible?
Andersen, D. K., Chari, S. T., Costello, E., Crnogorac‐Jurcevic, T., Hart, P. A., Maitra, A., & Pandol, S. J. (2021) · Wiley eBooks · doi:10.1002/9781119570097.ch51 · Cited by 2
Self-citationA multi-analyte serum biomarker panel for early detection of pancreatic adenocarcinomaPreprint
Firpo, M. A., Boucher, K. M., Bleicher, J. M., Khanderao, G. D., Rosati, A., Poruk, K. E., Kamal, S., Marzullo, L., Marco, M. D., Falco, A., et al. (2022) · medRxiv · doi:10.1101/2022.03.03.22271867 · Cited by 2
Self-citationAn Overview on Cancer Diagnosis based on Antibody-Based Immune Techniques
Nemati, A., Aghajanzadeh, M. S., & Rooberahan, M. (2020) · Modern Medical Laboratory Journal · doi:10.30699/mmlj17.3.1.100 · Cited by 1
Early Detection of Pancreatic Cancer: Recent Advancements
Konikoff, T. D., & Majumder, S. (2025) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-025-00480-w · Cited by 2
Du, Y. E., Bae, E. S., Bui, T. T. M., Lee, S. B., Kim, D., Park, J., Park, Y., Park, S. Y., Kang, S., Lee, B., et al. (2026) · Advanced Science · doi:10.1002/advs.202517849 · Cited by 1
Maitra, A., Chari, S. T., Wu, B., Eeden, S. K. V. D., Fisher, W., Vege, S. S., Rinaudo, J. A., Ziding, F., Hart, P. A., Brand, R. E., et al. (2026) · Pancreatology · doi:10.1016/j.pan.2026.04.020 · Cited by 1
Self-citationZhang, X., Wong, W., Cho, H. S., Yang, D., Dixon, G., Luo, R., Liu, D., Torre, D., Umeda, S., Gonzãlez, F., et al. (2026) · Developmental Cell · doi:10.1016/j.devcel.2026.04.012 · Cited by 2
Raj, F. J., Ruban, S. A., & Thangaraj, P. (2026) · Cell Biochemistry and Function · doi:10.1002/cbf.70249 · Cited by 1
Development of Novel Diagnostic Pancreatic Tumor Biomarkers 2nd ed
Oldfield, L. S., Rao, R. G., Barrera, L. N., & Costello, E. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_86-1 · Cited by 1
Idrees, M., Davies, A. L., Dent, J., Maurel, A., Jaques, B. C., & Bowles, T. (2021) · Australian Journal of Rural Health · doi:10.1111/ajr.12690 · Cited by 1
Metabolic Imaging Using Hyperpolarization for Assessment of Premalignancy
Pudakalakatti, S., Raj, P., Salzillo, T. C., Enriquez, J. S., Bourgeois, D., Dutta, P., Titus, M. A., Shams, S., Bhosale, P., Kim, M. P., et al. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2014-4_12 · Cited by 1
Diagnostic Applications of Nuclear Medicine: Pancreatic Cancer
Tabacchi, E., Nanni, C., Bossert, I., Maffione, A. M., & Fanti, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-26236-9_17 · Cited by 1
Vitamin D and pancreatic cancer
de Maturana, E. L., Zagorac, S., Malats, N., & Real, F. X. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91338-6.00042-2 · Cited by 1
Qiu, J., Li, K., Long, X., Yu, X., Gong, P., Long, Y., Wang, X., & Tian, L. (2024) · Cancer Medicine · doi:10.1002/cam4.7026 · Cited by 1
Ozaki, M., Kageyama, K., Kimura, K., Eguchi, S., Yamamoto, A., Tanaka, R., Nota, T., Yonezawa, H., Nishiofuku, H., Sakai, Y., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-61142-y · Cited by 1
Imaging Techniques and Biochemical Biomarkers: New Insights into Diagnosis of Pancreatic Cancer
Jafari, S. H., Lajevardi, Z. S., Fard, M. M. Z., Jafari, A., Naghavi, S., Ravaei, F., Taghavi, S. P., Mosadeghi, K., Zarepour, F., Mahjoubin‐Tehran, M., et al. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01437-z · Cited by 1
Screening for Pancreatic Cancer in Individuals With New-onset Diabetes Mellitus
Lo, T. (2018) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2018.07.010 · Cited by 1
Kang, J. A., Sin, J. H., Lee, H. L., Kim, H. R., Kim, S. H., Kang, M.-K., Yu, A., Son, M., Park, H.-J., & Lee, J. J. (2019) · International Journal of Pharmacology · doi:10.3923/ijp.2019.994.1000 · Cited by 1
Solide und zystische nichtendokrine Tumoren des Pankreas
Klöppel, G., Esposito, I., Kasajima, A., Konukiewitz, B., Lüttges, J., & Sipos, B. (2020) · Pathologie · doi:10.1007/978-3-642-04557-8_24 · Cited by 1
Diagnostic Applications of Nuclear Medicine: Pancreatic Cancer
Tabacchi, E., Nanni, C., Bossert, I., Maffione, A. M., & Fanti, S. (2022) · Springer eBooks · doi:10.1007/978-3-031-05494-5_17 · Cited by 1
Liquid biopsy-based biomarkers for early detection of pancreatic cancer
Fahrmann, J. F., Capello, M., & Hanash, S. (2018) · Precision Cancer Medicine · doi:10.21037/pcm.2018.10.01 · Cited by 1
Surgical techniques and tips for a reliable murine model of primary and metastatic pancreatic cancerPreprint
Hue, J. J., Zarei, M., Graor, H. J., Hajihassani, O., Katayama, E., Loftus, A. W., Gohar, A. V., & Winter, J. M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.30.502136 · Cited by 1
The Emerging Genetic Basis and Its Clinical Implication in Pancreatic Cancer
Chen, F., Guo, Y., & Wang, L. (2015) · Gastrointestinal Tumors · doi:10.1159/000435764
Development of Polymer Peptide Conjugates for Enhanced Pancreatic Cancer Imaging
Shi, W. (2015) · DigitalCommons@UNMC
Diagnostic Applications of Nuclear Medicine: Pancreatic Cancer
Tabacchi, E., Nanni, C., Bossert, I., Maffione, A. M., & Fanti, S. (2016) · Springer eBooks · doi:10.1007/978-3-319-26067-9_17-1
Pancreatic Carcinoma and Diabetes Mellitus
Czakó, L. (2017) · Gastroenterology & Hepatology Open Access · doi:10.15406/ghoa.2017.06.00203
Diagnosis and Screening for Pancreatic Malignancy
Janisch, N. H. (2017) · Springer eBooks · doi:10.1007/978-3-319-53091-8_10
Exosomes: Navigating a New Route in Pancreatic Cancer
Zhang, S. R., Wang, W. Q., Xu, J., Xu, H. X., Wu, C., Qi, Z. H., Gao, H., Ni, Q. X., Yu, X., & Liu, L. (2017) · Journal of Biomolecular Research & Therapeutics · doi:10.4172/2167-7956.1000149
Advanced Endoscopic Procedures
Farrell, J. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-58256-6_8
Management of Pain in Pancreatic Cancer
Erdek, M. A., Wilkinson, I., & Boomsaad, Z. E. (2018) · doi:10.1002/9781119188421.ch117
Baine, M. J., Kaur, S., Sasson, A. R., & Batra, S. K. (2014) · Springer eBooks · doi:10.1007/978-3-662-46875-3_7119
Self-citationThe role of endoscopic ultrasound in diagnosing pancreatic neuroendocrine tumours
Dyrla, P., Chmielewska, M., Mazur, M., & Witek, P. (2018) · Oncoreview · doi:10.24292/01.or.160218
Weaver, J. R., CASELLINI, C. M., Parson, H. K., & Vinik, A. I. (2018) · AACE Clinical Case Reports · doi:10.4158/accr-2017-0109
Self-citationMolecular Profiling in Pancreatic Ductal Adenocarcinoma
George, B. (2019) · Springer eBooks · doi:10.1007/978-3-319-98944-0_12
New Pharmacological Approaches for Pancreatic Cancer Therapy
Gupta, V. K., Banerjee, S., & Saluja, A. K. (2021) · doi:10.1002/9781119570097.ch69
Management of Pain in Pancreatic Cancer
Domínguez‐Muñoz, J. E. (2021) · doi:10.1002/9781119570097.ch62
Etiology and early detection of pancreatic cancer
Yu, J. (2021) · Figshare
Pathogenesis, Epidemiology, and Prognosis of Pancreatic Adenocarcinomas
Kim, K. K., Gaddam, S., & Liu, Q. Y. (2021) · Hepato-Pancreato-Biliary Malignancies · doi:10.1007/978-3-030-37482-2_28-1
Diagnosis and Evaluation of Pancreatic and Periampullary Adenocarcinoma
Lew, D., & Kwok, K. K. (2021) · Springer eBooks · doi:10.1007/978-3-030-37482-2_29-1
Zardab, M., Balarajah, V., Banerjee, A., Stasinos, K., Saad, A. B., Imrali, A., Hughes, C., Roberts, R., Vajrala, A., Chelala, C., et al. (2022) · medRxiv · doi:10.1101/2022.03.23.22272803
Diagnostic Applications of Nuclear Medicine: Pancreatic Cancer
Tabacchi, E., Nanni, C., Bossert, I., Maffione, A. M., & Fanti, S. (2022) · Springer eBooks · doi:10.1007/978-3-319-26067-9_17-4
Diagnostic Applications of Nuclear Medicine: Pancreatic Cancer
Tabacchi, E., Nanni, C., Bossert, I., Maffione, A. M., & Fanti, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-26067-9_17-3
Diagnostic Applications of Nuclear Medicine: Pancreatic Cancer
Tabacchi, E., Nanni, C., Bossert, I., Maffione, A. M., & Fanti, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-26067-9_17-2
The MD Anderson Cancer Center Moon Shots Program®: A Global Priority
Papadopoulos, P. C., Roarty, E. B., Bello, R. S., Domgue, J. F., Shete, S. S., & Maitra, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-69584-8.00062-1
Self-citationShaeir, S. S., Fouad, F. A., Elsebaiy, A., Sobeih, M. E., Desoky, E., Ahmed, A. S. O., Eltohamy, M. I., & Othman, H. F. (2022) · Medical Science · doi:10.54905/disssi/v26i125/ms290e2294
Baine, M. J., Kaur, S., Sasson, A. R., & Batra, S. K. (2014) · Springer eBooks · doi:10.1007/978-3-642-27841-9_7119-4
Self-citationDiagnosis and Evaluation of Pancreatic and Periampullary Adenocarcinoma
Lew, D., & Kwok, K. K. (2022) · Springer eBooks · doi:10.1007/978-3-030-41683-6_29
Pathogenesis, Epidemiology, and Prognosis of Pancreatic Adenocarcinomas
Kim, K. K., Gaddam, S., & Liu, Q. Y. (2022) · Springer eBooks · doi:10.1007/978-3-030-41683-6_28
Novel mRNA-based Immunological Biomarker for Early Detection of Resectable Pancreatic CancerPreprint
Lee, J.-C., Kim, H., Sim, E.-J., Cho, H., Youn, Y., Kim, J., Jeong, H.-H., Kim, J., & Hwang, J. (2023) · Research Square · doi:10.21203/rs.3.rs-2658368/v1
Management of Pain in Pancreatic Cancer
Hsu, A. W., Omosule, A. J., & Erdek, M. A. (2023) · doi:10.1002/9781119876007.ch154
Jia, E., Ren, N., Shi, X., Zhang, R., Yu, H., Yu, F., Qin, S., & Xue, J. (2022) · Figshare · doi:10.6084/m9.figshare.19845829
Cristancho, E. G., Bohórquez, E. J. F., Fierro, G. M. T., & Morales, D. (2024) · Revista Colombiana de Gastroenterología · doi:10.22516/25007440.1087
Kazemi-Harikandei, S.-Z., Karimi, A., & Tavangar, S. M. (2024) · Middle East Journal of Digestive Diseases · doi:10.34172/mejdd.2024.387
Wiegand, A., Chhoda, A., Namboodiri, A., Grimshaw, A. A., Dalela, D., & Farrell, J. J. (2025) · Journal of Genetic Counseling · doi:10.1002/jgc4.2016
Karakaş, D. (2025) · Acta Medica Nicomedia · doi:10.53446/actamednicomedia.1530253
Intersection of race and poverty for pancreatic adenocarcinoma: A public health crisis
Wu, C., Holland, M. M., Akinola, K. K., McLeod, C., Chen, H., Rose, J. B., Bhatia, R., & Gillis, A. (2025) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2025.116707
Zhang, M., Hu, X., Wang, X., & Xianghong, Y. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70590
Jia, E., Ren, N., Shi, X., Zhang, R., Yu, H., Yu, F., Qin, S., & Xue, J. (2022) · Figshare · doi:10.6084/m9.figshare.19845838
Jia, E., Ren, N., Shi, X., Zhang, R., Yu, H., Yu, F., Qin, S., & Xue, J. (2022) · Figshare · doi:10.6084/m9.figshare.19845832
Jia, E., Ren, N., Shi, X., Zhang, R., Yu, H., Yu, F., Qin, S., & Xue, J. (2022) · Figshare · doi:10.6084/m9.figshare.19845835
Zhang, X., Wong, W. D., Cho, H., Yang, D., Dixon, G., Luo, R., Liu, D., Torre, D., Umeda, S., Gonzãlez, F., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.09.710586
Chao, Y., Wang, H., Chen, Y.-L., Wang, C., Hou, Y., Kuo, Y.-T., Shin, J.-W., & Shan, Y.-S. (2026) · Cellular Oncology · doi:10.1007/s13402-026-01203-8
Gold Nanoparticles Combine with Radiation Therapy to Drive Immunogenic Macrophage Reprogramming
Iyer, S., Tabarrant, T., Ledoux, B., Michiels, C., & Heuskin, A. (2026) · ACS Applied Bio Materials · doi:10.1021/acsabm.6c00342 · Cited by 1
Ma, H., Lu, J., Gao, F., Luo, Z., Song, C., & Wang, X. M. (2026) · Journal of Physics and Chemistry of Solids · doi:10.1016/j.jpcs.2026.113939
Pachinger-Molnár, B., & Menyhárt, O. (2026) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2026.101326
Syed, M., Malik, A. N., Ahmad, M. W., Zubair, A., Touseef, M. M., Khalid, M., Kumar, P., Khan, J., Khan, M. A., Afzal, M. W., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10412967/v1
Metadata
- Authors
- Chari, S. T., Kelly, K., Hollingsworth, M. A., Thayer, S. P., Ahlquist, D. A., Andersen, D. K., Batra, S. K., Brentnall, T. A., Canto, M., Cleeter, D. F., Firpo, M. A., Gambhir, S. S., Go, V. L. W., Hines, O. J., Kenner, B. J., Klimstra, D. S., Lerch, M. M., Levy, M. J., Maitra, A., Mulvihill, S. J., Petersen, G. M., Rhim, A. D., Simeone, D. M., Srivastava, S., Tanaka, M., Vinik, A. I., & Wong, D.
- Affiliations
- Mayo Clinic (US)
- Eastern Virginia Medical School (US)
- University of California, Los Angeles (US)
- National Institutes of Health (US)
- The University of Texas MD Anderson Cancer Center (US)
- University of Washington (US)
- Corresponding author
- Chari, Suresh T.
- Ahlquist, David A.
- Canto, Marcia
- Klimstra, David S.
- Tanaka, Masao
- ORCID
- Chari, Suresh T.
- Hollingsworth, Michael A.
- Thayer, Sarah P.
- Ahlquist, David A.
- Andersen, Dana K.
- Batra, Surinder K.
- Brentnall, Teresa A.
- Canto, Marcia
- Firpo, Matthew A.
- Gambhir, Sanjiv Sam
- Hines, O. Joe
- Kenner, Barbara J.
- Klimstra, David S.
- Lerch, Markus M.
- Levy, Michael J.
- Maitra, Anirban
- Mulvihill, Sean J.
- Petersen, Gloria M.
- Rhim, Andrew D.
- Simeone, Diane M.
- Srivastava, Sudhir
- Tanaka, Masao
- Vinik, Aaron I.
- Venue
- Pancreas
- Published
- 2015-07
- Volume
- 44
- Issue
- 5
- Pages
- 693-712
- ISSN
- 0885-3177 (ISSN-L)
- PMC
- PMC4467589
- OpenAlex
- W2064141899
- Cited by
- 295
- References
- 0
- Citations by year
- 2026: 13 · 2025: 10 · 2024: 24 · 2023: 20 · 2022: 34 · 2021: 35 · 2020: 28 · 2019: 30 · 2018: 30 · 2017: 31 · 2016: 30 · 2015: 8
- FWCI
- 14.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Pancreas (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Cancer Institute (P50CA102701, R01CA168712, R01CA177857)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- pancreatic cancer, early detection, biomarkers, pancreatic imaging, familial pancreatic cancer, cancer survival, interdisciplinary collaboration, research gaps
- MeSH terms
- Biopsy, Congresses as Topic, Cooperative Behavior, Diagnostic Imaging, Diffusion of Innovation, Humans, International Cooperation, Pancreatic Neoplasms, Predictive Value of Tests, Prognosis, Biomarkers, Tumor, Survival Analysis, Carcinoma, Pancreatic Ductal, Molecular Diagnostic Techniques, Interdisciplinary Communication, Biomedical Research, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
